Post-market Reviews of Medicines to treat COPD and Ezetimibe
Page last updated: 16 October 2015
The public submission process for the Post-market Reviews of Chronic Obstructive Pulmonary Disease medicines and Ezetimibe are now open.
Interested organisations and individuals are invited to provide a submission addressing the Reviews Draft Terms of Reference. To make a submission please go to the relevant Public Consultation page:
- for COPD Medicines
- for Ezetimibe
The public submission process will be open for two weeks and will close at 5pm Friday, 30 October 2015.
